Answers are grounded in this paper and cite their sources.
Breast cancer is still a major health problem, and there is a need to look for other treatment strategies. Berberine is an important bioactive alkaloid found in Tinospora crispa that has shown promising anticancer properties, with prior studies reporting its cytotoxic effects on different cancer cell lines. The present study aims to evaluate the cytotoxic, network pharmacology, molecular docking analysis, and antioxidant activity of extracts and fractions of Tinospora crispa in T47D breast cancer cells. Fractions were obtained by maceration with methanol and subsequent acid-base separation. Cytotoxic activity was determined by MTT assay in T47D cells, and antioxidant activity was evaluated by DPPH radical scavenging; IC50 values were determined. The results showed that the pH 9 fraction exhibited moderate anticancer activity against T47D cells with an IC50 value of 172.27 ± 8.30 μg/mL and antioxidant activity with an IC50 value of 43.36 ± 0.08 μg/mL. To further investigate its anticancer potential, the network pharmacology approach was used to identify the key molecular targets of Tinospora-derived compounds. The network analysis showed that AKT1 was a key target related to breast cancer. Moreover, molecular docking studies revealed strong interaction of Tinospora-derived compounds with AKT1 which further support their possible role in breast cancer inhibition. These results shed light on the anticancer mechanisms of Tinospora crispa and open new avenues for further studies of its therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Frederica et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: